314 related articles for article (PubMed ID: 32633320)
1. Neutrophil elastase triggers the development of autoimmune diabetes by exacerbating innate immune responses in pancreatic islets of non-obese diabetic mice.
Shu L; Zhong L; Xiao Y; Wu X; Liu Y; Jiang X; Tang T; Hoo R; Zhou Z; Xu A
Clin Sci (Lond); 2020 Jul; 134(13):1679-1696. PubMed ID: 32633320
[TBL] [Abstract][Full Text] [Related]
2. Increased neutrophil elastase and proteinase 3 and augmented NETosis are closely associated with β-cell autoimmunity in patients with type 1 diabetes.
Wang Y; Xiao Y; Zhong L; Ye D; Zhang J; Tu Y; Bornstein SR; Zhou Z; Lam KS; Xu A
Diabetes; 2014 Dec; 63(12):4239-48. PubMed ID: 25092677
[TBL] [Abstract][Full Text] [Related]
3. Selective pharmacological inhibition of phosphoinositide 3-kinase p110delta opposes the progression of autoimmune diabetes in non-obese diabetic (NOD) mice.
Durand CA; Richer MJ; Brenker K; Graves M; Shanina I; Choi K; Horwitz MS; Puri KD; Gold MR
Autoimmunity; 2013 Feb; 46(1):62-73. PubMed ID: 23039284
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid binding protein 4 promotes autoimmune diabetes by recruitment and activation of pancreatic islet macrophages.
Xiao Y; Shu L; Wu X; Liu Y; Cheong LY; Liao B; Xiao X; Hoo RL; Zhou Z; Xu A
JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33690220
[TBL] [Abstract][Full Text] [Related]
5. Macrophages and β-cells are responsible for CXCR2-mediated neutrophil infiltration of the pancreas during autoimmune diabetes.
Diana J; Lehuen A
EMBO Mol Med; 2014 Aug; 6(8):1090-104. PubMed ID: 24968718
[TBL] [Abstract][Full Text] [Related]
6. In vivo imaging of type 1 diabetes immunopathology using eye-transplanted islets in NOD mice.
Abdulreda MH; Molano RD; Faleo G; Lopez-Cabezas M; Shishido A; Ulissi U; Fotino C; Hernandez LF; Tschiggfrie A; Aldrich VR; Tamayo-Garcia A; Bayer AS; Ricordi C; Caicedo A; Buchwald P; Pileggi A; Berggren PO
Diabetologia; 2019 Jul; 62(7):1237-1250. PubMed ID: 31087105
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil-Associated Inflammatory Changes in the Pre-Diabetic Pancreas of Early-Age NOD Mice.
Garciafigueroa Y; Phillips BE; Engman C; Trucco M; Giannoukakis N
Front Endocrinol (Lausanne); 2021; 12():565981. PubMed ID: 33776903
[TBL] [Abstract][Full Text] [Related]
8. Transgenic expression of haem oxygenase-1 in pancreatic beta cells protects non-obese mice used as a model of diabetes from autoimmune destruction and prolongs graft survival following islet transplantation.
Huang SH; Chu CH; Yu JC; Chuang WC; Lin GJ; Chen PL; Chou FC; Chau LY; Sytwu HK
Diabetologia; 2010 Nov; 53(11):2389-400. PubMed ID: 20683574
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse.
Stephens LA; Kay TW
Int Immunol; 1995 Dec; 7(12):1885-95. PubMed ID: 8746558
[TBL] [Abstract][Full Text] [Related]
10. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric enumeration of mononuclear cell populations infiltrating the islets of Langerhans in prediabetic NOD mice: development of a model of autoimmune insulitis for type I diabetes.
Jarpe AJ; Hickman MR; Anderson JT; Winter WE; Peck AB
Reg Immunol; 1990-1991; 3(6):305-17. PubMed ID: 2132756
[TBL] [Abstract][Full Text] [Related]
12. An immunohistochemical study of macrophage influx and the co-localization of inducible nitric oxide synthase in the pancreas of non-obese diabetic (NOD) mice during disease acceleration with cyclophosphamide.
Reddy S; Yip S; Karanam M; Poole CA; Ross JM
Histochem J; 1999 May; 31(5):303-14. PubMed ID: 10461865
[TBL] [Abstract][Full Text] [Related]
13. IL-10 Deficiency Accelerates Type 1 Diabetes Development
Huang J; Tan Q; Tai N; Pearson JA; Li Y; Chao C; Zhang L; Peng J; Xing Y; Zhang L; Hu Y; Zhou Z; Wong FS; Wen L
Front Immunol; 2021; 12():702955. PubMed ID: 34394099
[TBL] [Abstract][Full Text] [Related]
14. B cell depletion reduces T cell activation in pancreatic islets in a murine autoimmune diabetes model.
Da Rosa LC; Boldison J; De Leenheer E; Davies J; Wen L; Wong FS
Diabetologia; 2018 Jun; 61(6):1397-1410. PubMed ID: 29594371
[TBL] [Abstract][Full Text] [Related]
15. Resident macrophages of pancreatic islets have a seminal role in the initiation of autoimmune diabetes of NOD mice.
Carrero JA; McCarthy DP; Ferris ST; Wan X; Hu H; Zinselmeyer BH; Vomund AN; Unanue ER
Proc Natl Acad Sci U S A; 2017 Nov; 114(48):E10418-E10427. PubMed ID: 29133420
[TBL] [Abstract][Full Text] [Related]
16. Expression of intercellular adhesion molecule 1 on pancreatic beta-cells accelerates beta-cell destruction by cytotoxic T-cells in murine autoimmune diabetes.
Yagi N; Yokono K; Amano K; Nagata M; Tsukamoto K; Hasegawa Y; Yoneda R; Okamoto N; Moriyama H; Miki M
Diabetes; 1995 Jul; 44(7):744-52. PubMed ID: 7789642
[TBL] [Abstract][Full Text] [Related]
17. Development of insulitis and diabetes in B cell-deficient NOD mice.
Yang M; Charlton B; Gautam AM
J Autoimmun; 1997 Jun; 10(3):257-60. PubMed ID: 9218752
[TBL] [Abstract][Full Text] [Related]
18. In vivo islet protection by a nuclear import inhibitor in a mouse model of type 1 diabetes.
Moore DJ; Zienkiewicz J; Kendall PL; Liu D; Liu X; Veach RA; Collins RD; Hawiger J
PLoS One; 2010 Oct; 5(10):e13235. PubMed ID: 20949090
[TBL] [Abstract][Full Text] [Related]
19. AAV-mediated pancreatic overexpression of
Mallol C; Casana E; Jimenez V; Casellas A; Haurigot V; Jambrina C; Sacristan V; Morró M; Agudo J; Vilà L; Bosch F
Mol Metab; 2017 Jul; 6(7):664-680. PubMed ID: 28702323
[TBL] [Abstract][Full Text] [Related]
20. Islet abnormalities in the pathogenesis of autoimmune diabetes.
Rosmalen JG; Leenen PJ; Pelegri C; Drexhage HA; Homo-Delarche F
Trends Endocrinol Metab; 2002 Jul; 13(5):209-14. PubMed ID: 12185667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
